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Abstract
Background: Countrywide 5.9 million, 0-11 Month old children are immunized annually by EPI (Expended Program
on Immunization) against 8 vaccine preventable diseases including measles and so on. Unfortunately the basic
immunity centers are not uniform throughout the country. Each center provides services to about 27000 people
which is inadequate. The purpose of this study was to explore the development of EPI Pakistan in terms of
immunization of measles.
Methods: Nucleotide sequences were analyzed by neighbor joining method (bootstrap test) using Bio- edit and
MEGA-5 software to find evolutionary relationship between wild type measles strain and vaccine strain (Edmonston
strain) used in Pakistan. For statistical analysis of data SPSS 16 was used.
Results: Currently 1.3 vaccinators are working at each U C (union council) which according to national EPI policy
should be at least 2. About 56% and 44% children of age 0-11 months did not received second dose of measles in
the last two years respectively. Out of these 4231 cases which were reported last year, 1370 have received their
first dose of measles vaccine.
Conclusion: Seroconversion and seroprevalence study of the vaccine and field strain of measles virus is needed to
confirm whether its failure is due to service unavailability or vaccine in-affectivity.
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Introduction
Immunization is a sole component of preventive medi-
cine and is an important need of the day. Immunization
reduces the cost of treating diseases and thus helps in
poverty reduction and social and economic development
of the country [1]. Globally EPI was initiated by the
WHO In 1974 [2] and in Pakistan it was started in 1978
with the definitive objective of eliminating six common
diseases (Tetanus, Diphtheria, Tuberculosis, Pertussis,
Polio, and Measles) in the country which are vaccine
preventable [3].
For many years childhood immunization program cov-
erage remains low in Africa and Asia due to several rea-
sons. These countries carry an inconsistent burden of
global measles deaths. Approximately 610,000 infants
and young children died in 2002 in these continents. In
1997 a new resolution was adopted by Eastern Mediter-
ranean Region of the WHO to eliminate measles by
2010 [4]. The plan of National Immunization Days has
remarkable impact on immunization coverage [5].
Annually 5.9 million 0-11 month old children are
immunized by EPI Pakistan to protect them against 8
vaccine preventable diseases including measles. Unfortu-
nately the basic immunization providing centers are not
uniform in the country. About 6,000 fixed centers pro-
viding immunization services are present throughout the
country. Each center provides services to about 27,000
populations, which is inadequate and its distribution is
also not uniform. Presently 1.3 vaccinator are working
at each UC (union council) which according to national
EPI policy should be at least 2. In last 15 years the < 5
years mortality rates have shown some reduction but
still it is 94 out of 1000 live births which is obviously
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any medium, provided the original work is properly cited.terrifyingly [6]. About 56% and 44% children of age 0-11
months did not received measles II in the last two years
respectively. Pakistan has made significant improvement
in EPI coverage in comparison to India and Afghanistan.
But more forceful implementation strategy is required to
compete with other countries of the region.
Material and methods
Several Government documents, survey reports and
unpublished program documents were reviewed. Online
searches were also made to find literature on coverage
and surveillance of measles in Pakistan in websites of
the World Health Organization (WHO), United Nations
Children Fund (UNICEF) and other sources. EPI pro-
gram official database was also analyzed for this study.
12 nucleotide sequences of polyprotein gene of measles
virus strain reported in different areas of Pakistan and
that of Edmonston strain used in measles vaccine in
Pakistan were retrieved from NCBI gene Bank Data
Base. To study evolutionary relation between wild type
measles strain and Edmonston strain, nucleotide
sequences were analyzed by neighbor joining method
(bootstrap test) using Bio- edit and MEGA-5 software.
For statistical analysis and graph construction SPSS 16
was used.
Results
1. Need of Measles Vaccine
A highly infectious measles virus, have average of 12-
18 cases spread from each index case in a fully suscep-
tible population [7]. Measles virus behaves more like
the smallpox virus in terms of transmission factors
than the Polio virus and only replicates in humans.
Measles virus is highly infectious, due to that reason a
high level of population immunity is required to get
herd immunity. The protection provided by maternal
IgG decays by 6-9 months of age and infants becomes
susceptible to measles infection. A vaccinated mother,
who is never being exposed to circulating measles
virus transfer less number of maternal IgG to her child
as compare to mothers with a positive measles history.
Natural measles infection tends to induce higher anti-
body levels than does measles vaccination. World
Health Organization recommends vaccination at 9
months age which is significant for the reduction of
mortality caused by measles [8]. Despite the relatively
low (80-85%) seroconversion rates at 9 months of age
most developing countries recommends vaccination of
measles at this age because of high attack rates and
serious disease among infants. To ensure optimum
population immunity, all children should be given a
second opportunity for measles immunization. Table 1
summarize Dose vise Schedule of different vaccine fol-
lowed in Pakistan [9].
2. Vaccine Production in Pakistan
Killed measles vaccine was being used in the country
after its licensing in 1963, but because of severe atypical
pneumonia and high fever following subsequent exposure
to measles vaccine it was stopped. A live attenuated
measles vaccine originated from the Edmonston strain of
measles virus isolated by Enders and Peebles in 1954 is
now used in Pakistan since 1986. Measles vaccine has
remained efficacious and does not appear to revert back
in recipients because it is genetically very stable. The vac-
cine is produced by numerous passages of wild virus in
various cell cultures to become attenuated. Although the
Edmonston-derived vaccines have been developed in dif-
ferent types of cell cultures and have undergone different
numbers of passages, nucleotide sequence analysis of
selected genes shows minimal (< 0.6%) differences
between these vaccines. Sequence analysis of nucleopro-
tein gene of both wild type measles virus and vaccine
strain (Edmonston) used in Pakistan have a common
ancestry. The evolutionary history was inferred using the
Neighbor-Joining method [10]. The optimal tree with the
sum of branch length = 0.07305901 is shown in Figure 1.
The evolutionary distances were computed using the
Maximum Composite Likelihood method [11] and are in
the units of the number of base substitutions per site.
The analysis involved 12 nucleotide sequences. All posi-
tions containing gaps and missing data were eliminated.
There were a total of 456 positions in the final dataset.
Evolutionary analyses were conducted in MEGA5 [12].
Current measles vaccine being used in Pakistan have
been attenuated and produced in chick embryo fibroblasts.
The minimum quantity of vaccine virus per human dose is
determined by the national regulatory authority but is gen-
erally considered to be 1000 viral infective units [13]. The
vaccine induces both humoral and cellular immune
responses comparable to those following natural infection,
although the serological titers are usually lower. IgM, IgG
and IgA antibodies may be detected in both serum and
nasal secretions, and IgG persists for many years. Declin-
ing antibody titer may be boosted by revaccination or by
exposure to circulating measles virus.
3. Immunization Progress against Measles in Pakistan
The main body that has a key role in immunization of
children and pregnant mothers is the extended program
Table 1 Dose vise Schedule of different vaccine followed
in Pakistan.
Vaccine No. of Doses Age
BCG 1 At birth
Trivalent OPV 4 At birth,6,10 and 14 weeks
Measles 2 At 9 month and 2
nd year of life
Pentavalent 3 At 6,10 and 14 weeks after birth
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Pakistan. The target of EPI is to immunize children of
0-11 months against eight EPI target. Annually about
5.9 million children and 6 million pregnant women are
immunized against seven vaccine preventable diseases. It
was predicted that measles mortality level will be
reduced by 90% by 2010 as compared to 2000 but it has
to be achieved still. The Recent advancement in vaccines
and technologies has a considerable effect on immuniza-
tion [14]. However these achievements are inadequate
to reach the goal for polio eradication and measles elim-
ination from the country. Coverage for measles was
determined through different surveys conducted during
the period of 2001-2010 (Figure 2). According to all
surveys, the fully immunized child coverage ranged
between 47% and 57% with an exception in the Pakistan
Social and Living Standard Measurement Survey 2004-
2005 [15], which reflected a higher achievement. The
2001 EPI survey shows that KPK (Khyber Pakhtunkhwa)
province and FATA were the best performing regions
with 86% immunization for measles. While the densely
populated province “Punjab” shows 73% coverage.
EPI Coverage Evaluation Survey 2006 [16] and Paki-
stan Demographic and Health Survey 2006-2007 [17]
shows that only half of the target children were fully
immunized with all antigens. In 2009 and 2010 EPI sur-
veys indicate that in Punjab 100% children (0-11 month)
received first dose of measles but only 42% and 62%
Figure 2 Immunization of measles vaccine in Pakistan.
Figure 1 Evolutionary Relationships of Taxa. The percentage of replicate trees in which the associated Taxa clustered together in the
bootstrap test (500 replicates) is shown next to the branches [25]. The tree is drawn to scale, with branch lengths in the same units as those of
the evolutionary distances used to infer the phylogenetic tree. Abbreviations used: PAK-Pakistan, CAN-Canada and AFG-Afghanistan.
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respectively. Similarly 71% of 0-11 month children in
Sindh, 70% in KPK, 49% FATA and 56% of children in
Baluchistan received their first dose against measles in
2009 but all of them were deprived of their second dose
f o rm e a s l e s .I n2 0 1 0 ,4 3 %o fc h i l d r e ni nS i n d h ,3 0 %i n
KPK, 0% in FATA and only 20% of the children received
the second dose for measles because of great devastation
due to flood and terrorist activity in KPK and FATA
regions (Figure 3). In 2011, 89% immunization has been
achieved all over the country till last April [18].
4. Measles outbreaks in Pakistan
Despite impressive progress in some parts of the world,
measles still affects about 30 million persons each year, of
which an estimated 610,000 die and many more suffer
from complications and permanent sequelae. Despite of
enormous efforts of EPI and other private sectors to elimi-
nate measles, numbers of cases are reported each year.
Not only non-vaccinated children but those which are pre-
viously vaccinated also develop the disease (Figure 4).
The main reason behind the question “that how the
vaccinated children got the disease” is that most of
them do not receive booster dose which is very impor-
tant as recommended by WHO and Pakistan’s regula-
tory authorities. In the last decade, years 2001, 2006
and 2010 years are considered to be epidemic. 3849
cases were reported in 2001 and 6480 in 2006 at EPI
center Islamabad. Due to high efforts of bodies respon-
sible for immunization, the number of reported cases
reduced gradually in the next three years. However
due to floods in 2010 and the terrorist activities in the
past three years in KPK and FATA region a huge
number of children failed to received their first dose of
vaccine and almost all of them who have previously
received their first dose, failed to boost up immunity
against measles.
5. Reasons for poor coverage
EPI has raised its coverage up to 100% in some parts of
the country and has got many successes, but still it have
to tackle its goal of eliminating measles from the country.
The main hurdles in its way to fight against measles are;
a) The key reason for this poor performance is the
inadequate service delivery. Firstly the EPI centers
are far away from the citizens and they cannot afford
the cost to reach the center, secondly unavailability
of vaccinators was found to be the main reasons.
The 2006 Coverage Evaluation Survey of EPI indi-
cated that 12.6% of mother’sr e a s o n sf o rf a i l i n gt o
immunize their children were distant vaccine center
and unavailability of vaccinators [16].
Figure 4 Confirmed Measles cases reported in the last decade
in Pakistan.
Figure 3 2009-2010 survey results of Measles I and II immunization in different provinces of Pakistan.
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low coverage is the Lack of recipient awareness
about the immunization service and its benefits for
their children. Low coverage in Punjab is the lack of
parental awareness about the need for vaccination,
as indicated by The Coverage Evaluation Survey
Punjab 2003 [19].
c) Another main hurdle in vaccination progress is
that, the health facility doctors neither refer the chil-
dren for vaccination to the EPI center nor welcome
any EPI activity at their health centers.
Discussion
The administrative reports claimed high coverage but
only around half of the targeted children were fully
immunized as shown in all surveys conducted during
1995 to 2007 [15-17,19,20]. Concerns are found among
different stake holders about the inconsistency between
the reported data and independent assessments. Discre-
pancy in provincial performance was also evident in
these surveys. Poor performance and limited access to
the immunization service of EPI Pakistan, as revealed
through a series of studies, is the most common cause
for the large number of reported cases in the last decade
[16,19,21-25]. Inadequate numbers of vaccinators was
one of the main reasons for limited access to service
[22,24]. All provinces have a much lower number of vac-
cinators than required according to the national policy
except in Sindh (115%). Last year Proportions of vaccina-
tors available against the standard were 52%, 70% and
72%, in Punjab, Khyber Pakhtunkhwa and Baluchistan
provinces, respectively. A vaccinator working for 15-17
days every month making only 18-26 contacts each day is
sufficient for an average-sized Union Council with a
population of 25,000. However, this task becomes more
challenging due to wide geographical dispersion of this
target population. This inadequacy could be overcome by
using EPI-trained lady health workers for delivering vac-
cination services. LHWs are embedded in and easily
accepted by community. They have substantial potential
for enhancing EPI coverage in their catchment area.
Conclusion
Most of the children who have received their first dose
against measles are often deprived of their second dose,
due to which a large number of cases are reported each
year. The low rates of coverage and dropout rates sug-
gest that there is significant scope for improving effi-
ciency of the EPI. Further, to confirm efficacy of
measles vaccine we need seroconversion and seropreva-
lence study of the vaccine and field strain of measles
virus in the country.
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